Cetafen

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, backache, minor arthritis pain, the common cold, toothache, and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over are instructed to take 2 tablets every 4 to 6 hours as needed while symptoms persist. It is important not to exceed a total of 8 tablets within a 24-hour period unless directed by a healthcare professional.

For children under 12 years of age, it is recommended to consult a doctor for appropriate dosing guidance.

Contraindications

Use of this product is contraindicated in patients who are concurrently taking any other drug that contains acetaminophen, whether prescribed or over-the-counter. This is due to the potential risk of acetaminophen overdose, which can lead to severe liver damage.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen. Healthcare professionals should advise patients that the risk of liver injury increases significantly if they exceed 4,000 mg of acetaminophen within a 24-hour period, use other medications containing acetaminophen concurrently, or consume three or more alcoholic beverages daily while taking this product.

Patients should be informed of the potential for severe skin reactions associated with acetaminophen. Symptoms indicative of such reactions may include skin reddening, rash, and blisters. In the event of an allergic reaction, patients are advised to seek medical assistance immediately.

Patients should discontinue use and consult a healthcare provider if any of the following occur: an allergic reaction, the emergence of new symptoms, the presence of redness or swelling, a fever that worsens or persists for more than three days, or pain that worsens or lasts longer than ten days. These symptoms may indicate a serious underlying condition that requires further evaluation.

Prior to initiating treatment, patients with a history of liver disease should consult a healthcare professional. Additionally, individuals taking the anticoagulant warfarin or those uncertain about whether their other medications contain acetaminophen should seek guidance from a doctor or pharmacist before use. Monitoring for potential interactions and adverse effects is essential to ensure patient safety.

Side Effects

Patients using this product should be aware of potential adverse reactions, particularly those related to liver health and allergic responses.

Severe liver damage may occur if patients exceed 4,000 mg of acetaminophen within a 24-hour period, combine this product with other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using this product. An overdose, defined as taking more than the recommended dose, can also lead to liver damage, necessitating prompt medical attention for both adults and children, even in the absence of noticeable symptoms.

Patients should be vigilant for signs of severe allergic reactions, which may manifest as skin reddening, rash, or blisters. In the event of an allergic reaction, immediate medical assistance is crucial. Additionally, patients are advised to discontinue use and consult a healthcare professional if new symptoms arise, if redness or swelling occurs, if fever worsens or persists for more than three days, or if pain intensifies or lasts longer than ten days.

Patients with pre-existing liver disease should consult a doctor before using this product. Furthermore, individuals taking the blood-thinning medication warfarin or those uncertain if other medications contain acetaminophen should seek guidance from a healthcare provider or pharmacist prior to use.

Drug Interactions

Co-administration of this medication with any other drug containing acetaminophen, whether prescription or non-prescription, is contraindicated due to the risk of acetaminophen overdose, which can lead to severe liver damage.

Additionally, caution is advised when this medication is used in conjunction with warfarin, a blood-thinning agent. Patients should consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication if they are currently taking warfarin. Monitoring of coagulation parameters may be warranted to ensure safe and effective use.

Packaging & NDC

Below are the non-prescription pack sizes of Cetafen (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 2 tablets every 4 to 6 hours as needed for symptom relief, with a maximum of 8 tablets in a 24-hour period unless otherwise directed by a physician.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, which contains acetaminophen. It is important to note that severe liver damage may occur if patients exceed the following limits:

• More than 4,000 mg of acetaminophen in a 24-hour period.

• Concurrent use with other medications that also contain acetaminophen.

• Consumption of three or more alcoholic drinks daily while using this product.

Due to the potential for increased risk of liver toxicity, patients with compromised liver function should be closely monitored for signs of liver damage. It is advisable for these patients to consult with a healthcare professional before using this product to ensure safe and appropriate use.

Overdosage

Taking more than the recommended dose of this medication can lead to serious health consequences, particularly liver damage. It is imperative that both adults and children receive prompt medical attention in the event of an overdose, even if no immediate signs or symptoms are apparent.

In the case of suspected overdose, healthcare professionals are advised to seek medical help immediately or contact the Poison Control Center at 1-800-222-1222. Early intervention is crucial to mitigate potential harm and ensure appropriate management of the situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has identified that acetaminophen may be associated with severe skin reactions. Reports indicate that symptoms can include skin reddening, rash, and blisters. These events have been documented through voluntary reporting and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. Patients should be informed not to use this medication in conjunction with any other drug that contains acetaminophen, whether prescription or non-prescription, to avoid the risk of overdose.

Patients should be instructed to stop using the medication and seek medical attention if they experience any signs of an allergic reaction, such as difficulty breathing or swelling of the face, lips, or throat. They should also be advised to consult a doctor if new symptoms arise, if redness or swelling occurs, if a fever worsens or persists for more than three days, or if pain worsens or lasts longer than ten days, as these may indicate a serious underlying condition.

It is important for patients to consult with their healthcare provider before using this medication if they have a history of liver disease. Additionally, patients should be encouraged to speak with their doctor or pharmacist prior to use if they are currently taking the blood-thinning medication warfarin or if they are uncertain whether any other medications they are taking contain acetaminophen.

Storage and Handling

The product is supplied in sealed packets containing tablets. Each packet must be inspected prior to use; do not utilize any packet that is torn, cut, or open.

For optimal storage, maintain the product at a temperature range of 59° to 86°F (15° to 30°C). It is essential to protect the product from excessive heat and humidity to ensure its integrity and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cetafen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)